logo

PTC Therapeutics launches office at Dubai Science Park

Zawya12-05-2025
DUBAI - PTC Therapeutics, a global biopharmaceutical leader in rare diseases, has launched a Middle East and North Africa (MENA) office at Dubai Science Park to enhance access to transformative medicines for patients with rare diseases in the region.
Specialising in developing and commercialising breakthrough therapies for rare diseases globally, PTC's new facility will serve as a regional hub for its MENA operations, focused on delivering PTC's growing portfolio of innovative treatments and solutions to rare disease patients and enhancing health outcomes.
It is estimated that around 350 million people worldwide are affected by rare diseases, and around 2.8 million are known to have a rare disease in the Middle East region.
'We are excited to have a physical presence in the region and are looking forward to serve many more patients, across diverse portfolio of therapeutics areas, and with unwavering commitment,' said Zeina Sfeir, Head of MENA, PTC Therapeutics.
Marwan Abdulaziz Janahi, Senior Vice President of Dubai Science Park, part of TECOM Group PJSC, said, 'Dubai Science Park's ecosystem is a uniting platform for innovative researchers, clinicians, and biological pharmacists. We welcome partners such as PTC Therapeutics in our endeavour to translate scientific progress into effective therapies that improve health outcomes, contributing to Dubai Research and Development Programme, Dubai Economic Agenda 'D33', and We the UAE 2031.'
For almost 10 years, PTC has fostered long-standing partnerships with regional stakeholders and contributed to improving rare disease patient outcomes in the region with a transformative treatment for Duchenne Muscular Dystrophy (DMD) and a gene therapy for Aromatic L-amino Acid Decarboxylase (AADC) Deficiency.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How Abu Dhabi's halfway houses help recovering drug addicts return to society
How Abu Dhabi's halfway houses help recovering drug addicts return to society

Khaleej Times

timean hour ago

  • Khaleej Times

How Abu Dhabi's halfway houses help recovering drug addicts return to society

Abu Dhabi's halfway houses are offering recovering drug addicts more than a roof over their heads; they are providing structure, therapy, and a path back to society. The houses are backed by creative holistic treatment methods involving their family members and gradual release back to society; Khaleej Times spoke to field doctors who detailed how the project supports reintegration into society. Launched in May 2023 by the Family Care Authority (FCA), the halfway house project supports people after they complete medical detox or in-patient psychiatric care. 'The goal is to reintegrate into society and be an active person economically and socially after the treatment period,' said Salama Al Ameemi, Director General of the FCA. Unlike traditional rehabilitation centres, the FCA's halfway houses combine inpatient and outpatient services, with a capacity for 21 residential patients and up to 200 in outpatient care. Cases arrive through walk-ins, referrals from treatment facilities, or from the police, prosecutors and courts. 'What we do is basically rewiring human behaviour,' said Al Ameemi. 'We work on the psychological side, the emotional side, the professional side, and the quality of the person so that he can return to normal life and be able to take responsibility for himself.' A structured recovery The halfway house programme follows a phased approach. Dr Alyaa Aljasmi, Halfway Houses Division Manager, explained: 'The first phase is about medical stabilisation during the first month. The second phase is more about psychological and social rehabilitation, with specialised programmes such as behavioural therapy. The third phase is the reintegration phase, making sure the person can work, prepare for a job interview, and integrate gradually into society.' Daily life is highly structured. 'They wake up between 8.30 and 9am, have breakfast and medications, then meditation, followed by group therapy,' said psychiatrist Dr Shokry Alemam, chief doctor at the half-way facility. Sessions cover cognitive behavioural therapy, dialectical behavioural therapy, relapse prevention, and a 12-step programme. 'In the afternoon they have physical exercises, dedicated time for reading, homework, supervised entertainment,' he said. 'At the end of the day they have reflection sessions, and lights off by midnight.' Family at the core What sets Abu Dhabi's model apart is its integration of families into the recovery process. 'The international models are based on individualism. But here we're a collective society, so family is there,' said Al Ameemi. 'We believe this support system is very important, so they are not judged by society or their family.' Family involvement starts on day one. 'We do family counselling, family therapy, marital therapy, couple therapy, according to the marital status. Some families treat the beneficiary as if it's misbehaviour, not a disorder,' said Dr Shoukry. 'One of the major changes is to change the stigma, and understand that it's a disorder.' Preventing relapse Relapse prevention is a top priority for the programme, with individualised plans addressing three main risk factors — places, situations and people. 'We prepare the plan with them to avoid places with related memories and people who are active users,' said Dr Shokry. 'If they find themselves in a risky situation, they are more than welcome to join us again, just to protect themselves.' The approach appears to be working. 'Most of our beneficiaries have integrated successfully with their families; at least half of them have secured jobs in the private sector,' said Dr Alyaa Innovative therapies The halfway houses use a range of methods rarely seen in the region. Equine-assisted psychotherapy is led by renowned specialist Professor Andreas. 'Horses have the ability to reflect internal emotions, which helps beneficiaries express emotional conflicts they can't express verbally,' explained Dr Shokry. Neurofeedback targets specific brain areas linked to addiction, depression, ADHD and other conditions. 'We create a treatment plan, and the beneficiary receives at least 20 sessions for each method — this helps modify the function of brain cells to return to normal levels,' he said. Art and movement therapy further support emotional expression. A gradual return to life Integration into society is carefully paced. 'It's gradual; the patient goes home for two days and then stays at the halfway house. The days at home increase as we make sure he is applying the skills he learned,' said Dr Alyaa. 'If he (or she) faces challenges, they should go back to the medical team.' The programme is voluntary, which Al Ameemi considers a success factor in itself. 'As long as the person voluntarily wants to be treated, this is a success story,' she said. For many, the biggest fear is not drugs, but life itself. 'The speed of life makes them afraid. They live in structured environments for a long time, so when they leave, they feel they need to return to that structure,' explained Al Ameemi. 'They are also afraid their family will go back to doubt or lack of trust.' The FCA hopes the model will expand across Abu Dhabi emirate. 'We are here to support this group because they need this kind of medical and social support to return to normal life,' she added. 'When we succeed, we can go to the region and show it to people.'

Cruncho becomes first Kuwait-based company to earn Gluten-Free Certification and Non-GMO Verification from NSF
Cruncho becomes first Kuwait-based company to earn Gluten-Free Certification and Non-GMO Verification from NSF

Zawya

time4 hours ago

  • Zawya

Cruncho becomes first Kuwait-based company to earn Gluten-Free Certification and Non-GMO Verification from NSF

Dubai, UAE – NSF, a leading global public health and safety organization, proudly announces that Cruncho, a pioneering snack food manufacturer based in Kuwait, is the first company in the country to achieve both NSF Gluten-Free Certification and Non-GMO Project Verification for its flagship Prolife product line. This verification and certification marks a significant milestone for food safety and consumer health in the Middle East, aligning with the region's growing demand for transparent, health-conscious food options. With an estimated 1% of the global population affected by celiac disease, and much more affected by gluten sensitivities, and over 70% of Middle Eastern consumers preferring non-GMO (genetically modified) products, Cruncho's achievement directly addresses evolving market expectations. These verifications and certifications exemplify our commitment to advancing human health through rigorous, science-based standards. Cruncho's leadership in pursuing third-party verification reflects a broader regional shift toward transparency and consumer trust. As the first Kuwait-based company to receive both NSF Gluten-Free certification and Non-GMO Project Verification, Cruncho is setting a new benchmark for food safety and quality in the region.' Jyoti Bhasin, Managing Director, NSF Cruncho's Prolife brand offers a diverse range of protein-infused snacks tailored to various dietary needs, including high-protein puffs, pea-based chips, collagen-infused puffs and vitamin-enriched options. With over 1,000 points of sale across Kuwait and the GCC, Cruncho is rapidly becoming a household name in clean-label snacking. Earning both Gluten-Free certification and Non-GMO Project verification marks a pivotal moment for Cruncho. Consumers today are more conscious than ever about what goes into their food, and this certification and verification reinforce our promise to deliver clean-label snacks they can trust. These milestones demonstrate our commitment to delivering snacks that are not only delicious but also responsibly sourced and transparently labeled. We're grateful to NSF for their support throughout the verification and certification process.' Mohammed Ali Khan, Quality Assurance Officer, Cruncho NSF Gluten-Free Certification aligns with the U.S. Food and Drug Administration's Gluten-Free Labeling Final Rule, requiring certified products to contain less than 20 parts per million (ppm) of gluten. This certification ensures that products meet strict safety standards for individuals with celiac disease or gluten sensitivity. Non-GMO Project Verification is the most prevalent and trusted third-party standard for GMO avoidance. The verification process includes a comprehensive review of ingredient sourcing, supply chain documentation and testing protocols. With these certifications, Cruncho can now proudly display both the NSF Certified Gluten-Free mark and the Non-GMO Project Verified butterfly seal on its Prolife products. These marks signal to consumers that the products meet the rigorous requirements of the standards.' Sandy Talamonti, Senior Manager of Food Product Claims, NSF These certifications also support compliance with other major labeling requirements, including Whole Foods Market's GMO Labeling Policy and the USDA's National Bioengineered Food Disclosure Standard. To date, NSF has verified more than 12,000 products globally as non-GMO. The Middle East food industry is undergoing a transformation, with increasing consumer awareness around food safety, ingredient sourcing and dietary needs. Third-party certifications and verifications like those from NSF are becoming essential tools for brands looking to build trust and differentiate themselves in a competitive market.

ADFD: Strategic partner in advancing comprehensive Arab development
ADFD: Strategic partner in advancing comprehensive Arab development

Zawya

time5 hours ago

  • Zawya

ADFD: Strategic partner in advancing comprehensive Arab development

The Abu Dhabi Fund for Development (ADFD) has reinforced its position as one of the most prominent contributors in supporting economic and social progresses efforts in Arab countries, financing strategic projects that promote stability, drive growth and enhance quality of life, underscoring the UAE's steadfast commitment to its Arab neighbours. In recent years, the fund has broadened its engagement across the Arab region, translating its mission into tangible projects in vital sectors such as healthcare, energy and infrastructure, areas that are fundamental to the stability and future of communities. Each project represents a solid step forward in the path to comprehensive development. According to its 2024 Annual Report, ADFD's cumulative development financing reached AED216.5 billion, benefiting 107 countries across various continents. This total comprises AED157 billion in concessional loans, AED57.6 billion in government grants, and AED1.9 billion in direct contributions. In statements to the Emirates News Agency (WAM), the Fund said that in 2024 it managed six UAE government grants to Arab nations worth a combined AED810 million, benefiting Jordan, Morocco, Yemen and Mauritania. Jordan received more than AED452 million for three key projects: a national digital health transformation programme, budget support, and a reading skills development programme. Morocco was allocated AED129 million for the expansion of the Oued Akrach - Ain Aouda Road, Yemen received AED45 million for a solar power project in Socotra, and Mauritania was granted AED184 million for the Applied Sciences College. Among the standout initiatives is Jordan's recently launched 'Jordan Digital Health Centre', which aims to connect healthcare centres and create an integrated electronic medical records management system through a unified digital platform, to enhance Jordan's healthcare sector in delivering remote care services aligned with international standards. Phase one has already linked five hospitals in remote areas and three health centres across the kingdom, reflecting the depth of the UAE–Jordan cooperation in advancing development through digital innovation. The fund also oversees UAE grants under the Arab Gulf Programme for Development (AGFUND), with AED4.6 billion allocated each to Jordan and Morocco between 2012 and 2024 to support projects that directly improve citizens' lives. In the same period, Bahrain received an AED9.2 billion grant under the GCC Development Programme for major projects across various sectors. In 2025, ADFD has continued to implement high-impact investment projects across the Arab world. These include Egypt's 'Sofitel Legend Pyramids Giza' to support the tourism sector, an integrated tourism venture in Salalah, Oman, and the expansion of Bahrain International Airport. The fund has also advanced renewable energy in the Comoros through a solar power station, supported community stability in Somaliland with a housing project, and in June signed a financing agreement with the GCC Interconnection Authority for a strategic project to strengthen regional energy security. By championing strategic, high-value initiatives, the Abu Dhabi Fund for Development continues to act as a vital bridge for progress, reflecting the UAE's enduring commitment to spreading stability and prosperity across the Arab region and beyond.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store